Study your flashcards anywhere!

Download the official Cram app for free >

  • Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

A key: Read text to speech.a key


Play button


Play button




Click to flip

19 Cards in this Set

  • Front
  • Back
types cardiomyopathies and typical dysfunction
1) Dilated: impaired systolic contraction

2) Hypertrophic: impaired diastolic relaxation (usually intact systolic)

3) restrictive: abnormally stiff, impaired diastolic relaxation

LA enlargement is common to all three types
definition cardiomyopathy
group of heart disorders in which major structural abnormality is limited to the myocardium
- often result in symptoms of heart failure
LA enlargement is common to all types

excludes heart impairment from other defined CV diseases

many times etiology remains unknown
Etiology of DCM
1) Idiopathic
2) Familial/genetic
3) Inflammatory:
- progression of viral myocarditis (immune-mediated injury?)
= coxsackievirus group B
= parvovirus B19
= adenovirus etc
Non infectious:
- peripartum CM - HF symptoms in last month of pregnancy - 6m postpartum
- CT disease
- Sarcoidosis
4) Toxic
- alcoholic CM - potentially reversible if identified!
- chemotherapeutic agents
5) Metabolic
- Hyperthyroidism
- Chronic hypoCa+ or hypophosphatemia
6) Neuromuscular
increased risk of thromboembolic complication in DCM because:
1) stasis in ventricles from poor systolic funciton

2) stasis in atria due to chamber enlargement or a Fib

3) venous stasis from poor circulatory flow

definite anticoags if:
A fib
previous TE
intercardiac thrombus visualized w Echo

LV EF <30% probably anticoag
Treatment considerations in DCM
1) tx HF: diuretics, vasodilator (ACE inhib, ARB); beta-blocker

2) prevent and tx arrythmias
- maintain electrolyte balance
- amiodrone
- ICD*
- cardiac resynchronization therapy

3) Prevent thromboebolic events
- anticoagulants

4) Cardiac transplant - better 5 yr prognosis than other tx
definition HCM
usually asymmetric LV hypertrophy (90% cases septum) NOT caused by chronic pressure overload (ie systemic HTN or aortic stenosis)

thick muscle = stiff = impaired relaxation/filling and high diastolic pressures; also arrythmias

may have transient obstruction of LV outflow during systole

hypertrophy = chaotic, disarray
HCM etiology
autosomal dominant
variable penetrance
100s of mutations
- all part of sarcomere complex = impaired contractile fn = compensatory hypertrophy and proliferation of fibroblasts
cause of outflow obstruction in HCM
1) rapid blood flow toward aortic valve from narrowed outflow tract

2) rapid flow creates Venturi forces that draw anterior mitral valve leaflet toward septum

3) valve leaflet abuts hypertrophied septum = transient obstruction of blood flow into aorta

negative inotropic drugs and conditions that enlarge LV increase distance bw valve leaflet and septum = reduced obstruction; vice versa for conditions that decrease LV size, and positive inotropic drugs
Clinical findings HCM
- presentation mid 20s
- dyspnea (^ diastolic P > ^ pulm cap P)
- angina (high O2 demand, narrowed smaller branches of coronary arteries in walls)
- syncope (arrhythmias; a fib not well tolerated; v fib may cause sudden cardiac death)
- S4, double apical impulse
orthostatic lightheadedness in pts with HCM and outflow tract obstruction
- venous return to heart decreases on standing from pooling of blood in lower extremities
= decrease size LV
= intensified outflow tract obstruction
= reduced CO and cerebral perfusion
Risk factors for sudden death in HCM
- history of syncope
- fam hx sudden death
- some high risk HCM mutations
- extreme hypertrophy (>30mm in thickness)

incidence: 2-4% adults, 4-6% kids/adolescents
- LVH, LA enlargement
- Prominent Q waves in inf and lat leads from amplified initial depol in enlarged septum
- sometimes diffuse T wave inversions
- A and V arrhythmias
HCM treatment
1) Beta blockers
= reduced MO2 demand (decrease angina and dyspnea)
= ^ passive diastolic filling time (bc dec HR)
= decrease hz ventricular ectopic beats
2) Ca Channel antagonists: reduce V stiffness
3) careful use diuretics to decrease pulm congestion w/o volume depletion
4) antiarrhythmics to avoid a fib (amidrone)
5) avoid strenuous exercise
6) ICD if high risk v fib
7) myomectomy for those who dont respond to pharma - excision hypertrophied septum; percutaneous septal ablation
definition RCM
characterized by abnormally rigid, but not necessarily thickened, ventricles
= impaired diastolic filling
- normal/near norm systole

results from:
1) fibrosis/scarring of endomyocardium
2) infiltration of myocardium by abnormal substance
most common recognized cause of RCM in nontropical countries

insoluble misfolded amyloid fibrils deposit in tissues
1* - tumor secretion - see most clinical cardiac issues
2* - chronic inflam conditions
hereditary - point mutations
consequences of RCM
1) elevated systemic and pulmonary venous pressures, signs of R and L vascular congestion

2) reduced ventricular cavity size w decreased SV and CO
differentiation of RCM from constrictive pericarditis
-transvenous endomyocardial biopsy (presence of infiltrates)
- CT
(both see thickened pericardium)
treatment RCM
- treat underlying cause!
- symptomatic tx
= salt restriction, cautious use diuretics to improve congestion
= maintenance sinus rhythm
= oral anticoags
etiologies of RCM
- idiopathic
- scleroderma
- Amyloidosis
- Sarcoidosis
Storage diseases:
- Hemochromatosis
- Glycogen storage diseases
Endomyocardial disease:
- endomyocardial fibrosis
- metastatic tumors
- radiation therapy